Drugs / D390
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04221360 | Jan → Mar 2020 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D390 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04221360 ↗ |
| Route | Oral | “Reference drug, QD, PO” NCT04221360 ↗ |